Long COVID Research Is In Its ‘Most Hopeful’ Phase Yet ...Middle East

A phenomenal amount of research on Long COVID—the name for chronic symptoms following a case of COVID-19—has been published over the past three years. But scientific advances have yet to bring relief to people who are already sick, a group estimated to include about 5% of U.S. adults but hard to precisely quantify due to the difficulty of diagnosing people correctly. Researchers are optimistic that breakthroughs are coming. The U.S. National Institutes of Health (NIH) has launched multiple clinical trials focused on potential therapies, and several recent studies have pointed to biomarkers that may help doctors accurately diagnose—and, hopefully, treat—people with Long COVID. [tim

Hence then, the article about long covid research is in its most hopeful phase yet was published today ( Monday 23/10/2023 - 07:12 PM ) and is available on Time ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Long COVID Research Is In Its ‘Most Hopeful’ Phase Yet )

Also on site :

• Emmys 2026: ‘Widow’s Bay’ Leads All New Shows With 19 Nominations
• Dem Sen. Mark Kelly's Warning About How Trump Might Try to 'Intimidate Voters' Is Backfiring Hard
• Northwest Biotherapeutics Presents Updated Survival Data from Phase III Trial of DCVax®-L For Glioblastoma Using Individual Patient Level Data in Multiple Independent Analyses